Annual Total Expenses
$1.14 B
+$186.00 M+19.44%
31 December 2023
Summary:
United Therapeutics annual total expenses is currently $1.14 billion, with the most recent change of +$186.00 million (+19.44%) on 31 December 2023. During the last 3 years, it has risen by +$13.00 million (+1.15%). UTHR annual total expenses is now -30.18% below its all-time high of $1.64 billion, reached on 31 December 2019.UTHR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$340.70 M
-$54.30 M-13.75%
30 September 2024
Summary:
United Therapeutics quarterly total expenses is currently $340.70 million, with the most recent change of -$54.30 million (-13.75%) on 30 September 2024. Over the past year, it has dropped by -$13.90 million (-3.92%). UTHR quarterly total expenses is now -66.55% below its all-time high of $1.02 billion, reached on 31 March 2019.UTHR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -3.9% |
| 3 y3 years | +1.1% | +38.8% |
| 5 y5 years | -30.2% | +37.6% |
UTHR Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +19.4% | -13.8% | +95.9% |
| 5 y | 5 years | -30.2% | +28.4% | -23.3% | +114.3% |
| alltime | all time | -30.2% | +8426.9% | -66.5% | >+9999.0% |
United Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $340.70 M(-13.7%) |
| June 2024 | - | $395.00 M(+22.9%) |
| Mar 2024 | - | $321.40 M(-9.4%) |
| Dec 2023 | $1.14 B(+19.4%) | $354.60 M(+25.6%) |
| Sept 2023 | - | $282.40 M(-0.2%) |
| June 2023 | - | $283.10 M(+27.2%) |
| Mar 2023 | - | $222.50 M(-29.6%) |
| Dec 2022 | $956.60 M(-15.3%) | $315.90 M(+56.6%) |
| Sept 2022 | - | $201.70 M(-23.9%) |
| June 2022 | - | $265.10 M(+52.4%) |
| Mar 2022 | - | $173.90 M(-29.1%) |
| Dec 2021 | $1.13 B(+27.0%) | $245.40 M(+13.6%) |
| Sept 2021 | - | $216.00 M(-3.7%) |
| June 2021 | - | $224.30 M(-49.5%) |
| Mar 2021 | - | $443.90 M(+38.9%) |
| Dec 2020 | $889.70 M(-45.6%) | $319.60 M(+101.0%) |
| Sept 2020 | - | $159.00 M(-28.2%) |
| June 2020 | - | $221.50 M(+16.8%) |
| Mar 2020 | - | $189.60 M(-23.4%) |
| Dec 2019 | $1.64 B(+99.0%) | $247.60 M(+13.5%) |
| Sept 2019 | - | $218.10 M(+43.3%) |
| June 2019 | - | $152.20 M(-85.1%) |
| Mar 2019 | - | $1.02 B(+307.6%) |
| Dec 2018 | $822.40 M(+17.4%) | $249.90 M(-5.0%) |
| Sept 2018 | - | $263.10 M(+15.9%) |
| June 2018 | - | $227.10 M(+175.9%) |
| Mar 2018 | - | $82.30 M(-74.7%) |
| Dec 2017 | $700.40 M(+30.4%) | $325.70 M(+167.6%) |
| Sept 2017 | - | $121.70 M(-16.7%) |
| June 2017 | - | $146.10 M(+36.7%) |
| Mar 2017 | - | $106.90 M(-54.5%) |
| Dec 2016 | $537.10 M(-30.0%) | $234.80 M(+38.4%) |
| Sept 2016 | - | $169.60 M(+33.1%) |
| June 2016 | - | $127.40 M(+2303.8%) |
| Mar 2016 | - | $5.30 M(-97.9%) |
| Dec 2015 | $766.80 M(+2.3%) | $249.90 M(<-9900.0%) |
| Sept 2015 | - | -$800.00 K(-100.5%) |
| June 2015 | - | $175.40 M(-48.8%) |
| Mar 2015 | - | $342.30 M(+104.0%) |
| Dec 2014 | $749.70 M(-9.1%) | $167.77 M(-53.7%) |
| Sept 2014 | - | $362.19 M(+147.3%) |
| June 2014 | - | $146.48 M(+99.9%) |
| Mar 2014 | - | $73.26 M(-76.9%) |
| Dec 2013 | $824.49 M(+66.8%) | $317.51 M(+60.7%) |
| Sept 2013 | - | $197.58 M(+24.8%) |
| June 2013 | - | $158.30 M(+4.8%) |
| Mar 2013 | - | $151.10 M(+31.1%) |
| Dec 2012 | $494.43 M(+16.2%) | $115.21 M(-28.8%) |
| Sept 2012 | - | $161.75 M(+34.8%) |
| June 2012 | - | $119.99 M(+23.1%) |
| Mar 2012 | - | $97.48 M(-26.0%) |
| Dec 2011 | $425.40 M | $131.67 M(+33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $98.77 M(+42.6%) |
| June 2011 | - | $69.26 M(-44.9%) |
| Mar 2011 | - | $125.71 M(-15.3%) |
| Dec 2010 | $421.59 M(+22.6%) | $148.36 M(+39.8%) |
| Sept 2010 | - | $106.08 M(+82.1%) |
| June 2010 | - | $58.24 M(-39.7%) |
| Mar 2010 | - | $96.63 M(-13.0%) |
| Dec 2009 | $343.85 M(-5.4%) | $111.11 M(+30.0%) |
| Sept 2009 | - | $85.48 M(-3.0%) |
| June 2009 | - | $88.10 M(+48.9%) |
| Mar 2009 | - | $59.16 M(-71.8%) |
| Dec 2008 | $363.55 M(+77.7%) | $209.72 M(+268.1%) |
| Sept 2008 | - | $56.97 M(+14.9%) |
| June 2008 | - | $49.57 M(+4.8%) |
| Mar 2008 | - | $47.29 M(-30.7%) |
| Dec 2007 | $204.64 M(+56.6%) | $68.29 M(+52.1%) |
| Sept 2007 | - | $44.89 M(+2.5%) |
| June 2007 | - | $43.79 M(-8.2%) |
| Mar 2007 | - | $47.67 M(+12.8%) |
| Dec 2006 | $130.65 M(+78.9%) | $42.28 M(+46.0%) |
| Sept 2006 | - | $28.96 M(+0.8%) |
| June 2006 | - | $28.73 M(-6.4%) |
| Mar 2006 | - | $30.68 M(+59.1%) |
| Dec 2005 | $73.02 M(+20.9%) | $19.29 M(+4.4%) |
| Sept 2005 | - | $18.48 M(-2.2%) |
| June 2005 | - | $18.89 M(+15.4%) |
| Mar 2005 | - | $16.37 M(+7.0%) |
| Dec 2004 | $60.38 M(-6.9%) | $15.30 M(+7.0%) |
| Sept 2004 | - | $14.30 M(-2.9%) |
| June 2004 | - | $14.73 M(-8.3%) |
| Mar 2004 | - | $16.06 M(-6.2%) |
| Dec 2003 | $64.87 M(+34.8%) | $17.11 M(+2.0%) |
| Sept 2003 | - | $16.78 M(-0.2%) |
| June 2003 | - | $16.80 M(+18.6%) |
| Mar 2003 | - | $14.17 M(-6.4%) |
| Dec 2002 | $48.12 M(-8.6%) | $15.13 M(+29.7%) |
| Sept 2002 | - | $11.66 M(-9.9%) |
| June 2002 | - | $12.94 M(+54.4%) |
| Mar 2002 | - | $8.38 M(-24.7%) |
| Dec 2001 | $52.67 M(-37.0%) | $11.13 M(-15.8%) |
| Sept 2001 | - | $13.21 M(-7.5%) |
| June 2001 | - | $14.29 M(+6.8%) |
| Mar 2001 | - | $13.38 M(-58.0%) |
| Dec 2000 | $83.55 M(+133.4%) | $31.86 M(+194.3%) |
| Sept 2000 | - | $10.83 M(-65.1%) |
| June 2000 | - | $31.07 M(+217.1%) |
| Mar 2000 | - | $9.80 M(+1.0%) |
| Dec 1999 | $35.80 M(+167.2%) | $9.70 M(+34.7%) |
| Sept 1999 | - | $7.20 M(+14.3%) |
| June 1999 | - | $6.30 M(-49.2%) |
| Mar 1999 | - | $12.40 M |
| Dec 1998 | $13.40 M | - |
FAQ
- What is United Therapeutics annual total expenses?
- What is the all time high annual total expenses for United Therapeutics?
- What is United Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for United Therapeutics?
- What is United Therapeutics quarterly total expenses year-on-year change?
What is United Therapeutics annual total expenses?
The current annual total expenses of UTHR is $1.14 B
What is the all time high annual total expenses for United Therapeutics?
United Therapeutics all-time high annual total expenses is $1.64 B
What is United Therapeutics quarterly total expenses?
The current quarterly total expenses of UTHR is $340.70 M
What is the all time high quarterly total expenses for United Therapeutics?
United Therapeutics all-time high quarterly total expenses is $1.02 B
What is United Therapeutics quarterly total expenses year-on-year change?
Over the past year, UTHR quarterly total expenses has changed by -$13.90 M (-3.92%)